Are you Dr. Gyurkocza?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000Fax+1 212-639-5301
Summary
- Dr. Boglarka Gyurkocza, MD is an oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington, Florida, and New Jersey. She is affiliated with Fred Hutchinson Cancer Center and is an Instructor at University of Washington School of Medicine.
Education & Training
- UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 2003 - 2006
- Westchester Medical CenterResidency, Internal Medicine, 2000 - 2003
- Semmelweis UniversityClass of 1999
Certifications & Licensure
- FL State Medical License 2022 - Present
- WA State Medical License 2006 - 2026
- NJ State Medical License 2021 - 2025
- NY State Medical License 2013 - 2025
- MA State Medical License 2006 - 2007
- American Board of Internal Medicine Hematology
Clinical Trials
- Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia Start of enrollment: 2009 Feb 01
- Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant Start of enrollment: 2011 Jan 25
- Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia Start of enrollment: 2016 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 374 citationsIncreased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and miceYusuke Shono, Melissa D. Docampo, Jonathan U. Peled, Suelen M. Perobelli, Enrico Velardi
Science Translational Medicine. 2016-05-18 - 214 citationsIntestinal Microbiota and Relapse After Hematopoietic-Cell TransplantationJonathan U. Peled, Sean M. Devlin, Anna Staffas, Melissa Lumish, Raya Khanin
Journal of Clinical Oncology. 2017-03-15 - 30 citationsHigh progression-free survival after intermediate intensity double unit cord blood transplantation in adultsJuliet N. Barker, Sean M. Devlin, Kristine Naputo, Kelcey Skinner, Molly Maloy
Blood Advances. 2020-12-08
Press Mentions
- Bringing Transplant to More Patients with AMLFebruary 25th, 2020